Skip to main content
Log in

Malondialdehyde; Lipid peroxidation plasma biomarker correlated with hepatic fibrosis in human Schistosoma mansoni infection

  • Published:
Acta Parasitologica Aims and scope Submit manuscript

Abstract

Schistosomiasis is a debilitating parasitic disease, affects large number of host species. Currently affects 250–300 million people in tropic areas. Schistosoma pathogenic impact is hepatic periportal fibrosis; the parasite-induced inflammatory cellular activation promotes oxidative stress, resulting in lipid peroxidation (LPO), with subsequent increase in inflammatory mediators as malondialdehyde (MDA). This study was set up to reveal possible contribution of lipid peroxidation byproducts MDA in hepatic pathophysiology. Results displayed that MDA don’t tend to change in relation with either age, nor hepatic transaminases AST & ALT, while exhibited a significant increase in MDA levels in human schistosomiasis versus control group P<0.0001 (Mn. ± St.dev. 7.77 ± 3.59, 1.21 ± 0.28 nmol/ml) respectively. Moreover; MDA plasma levels in Schistosoma infected group correlated significantly with two hepatic fibrosis parameters; (a) ultrasonography graded periportal fibrosis P< 0.0001. Levels of MDA in hepatic fibrosis grades 0, I, II, III in Schistosoma infected group were (Mn. ± St.dev. 2.8 ± 0.64, 4.3 ± 1.2, 9.3 ± 1.6 and 10.8 ± 1.3 nmol/ml) respectively, (b) serum Hyaluronic acid (HA) P<0.0001 (spearman r = 0.77) as a reliable hepatic fibrosis marker. This implies a considerable role of LPO byproducts in schistosomiasis pathogenicity, and proposing malondi-aldehyde as a biomarker for schistosomiasis morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abdallahi O.M., Hanna S., De Reggi M., Gharib B. 1999. Visualization of oxygen radical production in mouse liver in response to infection with Schistosoma mansoni. Liver, 19, 495–500

    Article  CAS  Google Scholar 

  • Abou-El-Naga I.F., 2013. Biomphalaria alexandrina in Egypt: Past, present and future. Journal of Biosciences, 38, 665–672. DOI: 10.1007/s12038-013-9329-4

    Article  Google Scholar 

  • Barros A.F., Oliveira S.A., Carvalho C.L., Silva F.L., de Souza V.A., Da Silva A.L., De Araujo R.E., Souza, B.S., Soares M.B.P., Costa V.M., Coutinho E.D. 2014. Low transformation growth factor-ß1 production and collagen synthesis correlate with the lack of hepatic periportal fibrosis development in undernourished mice infected with Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz, 109, 210–219. DOI: 10.1590/0074-0276140266

    Article  CAS  Google Scholar 

  • Coutinho E.M., Silva F.L., Barros A.F., Araújo R.E., Oliveira S.A.L., Carlos F.B., Aryon A.A., Zilton A. 2007. Repeated infections with Schistosoma mansoni and liver fibrosis in undernourished mice. Acta Tropica, 101, 15–24. DOI: 10.1016/j.actat-ropica.2006.03.006

    Article  Google Scholar 

  • Coutinho H.M., McGarvey S.T., Acosta L.P., Manalo D.L., Langdon G.C., Leenstra T., Kanzaria H.K., Solomon J., Wu H., Olveda R., Kurtis J.D., Friedman J.F. 2005. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibro-sis, in Leyte, Philippines. The Journal of Infectious Diseases, 192, 528–36. DOI: 10.1086/430929

    Article  Google Scholar 

  • Cunha G.M., Silva V.M.A., Bessa K.D.G., Bitencourt M.A.O., Macêdo U.B.O., Freire-Neto F.P., Martins R.R., Assis C.F., Lemos T.M.A.M., Almeida M.G., Freire A.C.G. 2012. Levels of oxidative stress markers: correlation with hepatic function and worm burden patients with schistosomiasis. Acta Parasitologica, 57, 160–166. DOI: 10.2478/s11686-012-0026-5

    Article  CAS  Google Scholar 

  • Dessein A.J., Marquet S., Henri S.E.I., Wali N.E., Hillaire D., Rodrigues V., Prata A., Ali Q.M., Gharib, B., de Reggi M., Magzoub M.M., Saeed O.K., Abdelhameed A.A., Abel L. 1999. Infection and disease in human schistosomiasis mansoni are under distinct major gene control. Microbes and Infection, 1, 561–567

    Article  CAS  Google Scholar 

  • Domingues A.L.C., Medeiros T.B., Lopes E.P. de A. 2011. Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz, 106, 802–807

    Article  Google Scholar 

  • Eboumbou C., Steghens J.P., Abdallahi O.M.S., Mirghani A., Gallian P., van Kappel A., Qurashi A., Gharib B., De Reggi M. 2005. Circulating markers of oxidative stress and liver fibro-sis in Sudanese subjects at risk of schistosomiasis and hepatitis. Acta Tropica, 94, 99–106. DOI: 10.1016/j.actatropica. 2005.03.001

    Article  CAS  Google Scholar 

  • Elsammak M.Y., Al-Sharkaweey R.M., Ragab M.S., Amin G.A., Kandil M.H. 2008. IL-4 and reactive oxygen species are elevated in Egyptian patients affected with schistosomal liver disease. Parasite Immunology, 30, 603–609. DOI: 10.1111/j.1365-3024.2008.01061.x

    PubMed  CAS  Google Scholar 

  • Esterbauer H., Schaur R.J., Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine, 11, 81–128

    Article  CAS  Google Scholar 

  • Esterbauer H. 1993. Cytotoxicity and genotoxicity of lipidoxidation products. The American Journal of Clinical Nutrition, 57, 779S–785S

    Article  CAS  Google Scholar 

  • Facundo H.T.F., Brandt C.T., Owen J.S., Lima V.L.M. 2004. Elevated levels of erythrocyte-conjugated dienes indicate increased lipid peroxidation in schistosomiasis mansoni patients. Brazilian Journal Of Medical and Biological Research, 37, 957–962. DOI: /S0100-879X2004000700003

    Article  CAS  Google Scholar 

  • Gil L., Siems W., Mazurek B., Gross J., Schroeder P., Voss P., Grune T. 2006. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res, 40, 495–505. DOI: 10.1080/10715760600592962

    Article  CAS  Google Scholar 

  • Gordon C.C., and Alimuddin I.Z. 2003. Manson’s Tropical Diseases. W.B. Saunders, USA, Philadelphia

    Google Scholar 

  • Grigorescu M., 2006. Noninvasive Biochemical Markers of Liver Fibrosis. Journal of Gastrointestinal and Liver Diseases, 15, 149–159

    PubMed  Google Scholar 

  • Gutteridge J.M., Halliwell B. 1990. The measurement and mechanism of lipid peroxidation in biological systems. Trends in Biochemical Sciences, 15, 129–135

    Article  CAS  Google Scholar 

  • Halfon P., Bourlière M., Pénaranda G., Deydier R., Renou C., Botta-Fridlund D., Tran A., Portal I., Allemand I., Rosenthal-Allieri A., Ouzan D. 2005. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comparative Hepatology, 4, 6. DOI: 10.1186/1476-5926-4-6

    Article  CAS  Google Scholar 

  • Hotez P.J., Molyneux D.H., Fenwick A., Ottesen E., Ehrlich Sachs S., Sachs Je. D. 2006. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med, 3, e102. DOI: 10. 1371/journal.pmed.0030102

    Article  Google Scholar 

  • King C.H., Dickman K., Tisch D.J. 2005. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet, 365, 1561–1569. DOI: 10.1016/S0140-6736(05)66457-4

    Article  Google Scholar 

  • Köpke-Aguiar L., Martins J.R., Passerotti C., Toledo C.F., Nader H.B., Borges D.R. 2002. Serum hyaluronic acid as a comprehensive marker to assess severity of liver disease in schisto-somiasis. Acta Tropica, 84, 117–126. DOI: 10.1016/S0001-706X(02)00136-5

    Article  Google Scholar 

  • Lefèvre G., Beljean-Leymarie M., Beyerle F., Bonnefont-Rousselot D., Cristol J.P., Thérond P., Torreilles J. 1998. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Annales De Biologie Clinique (Paris), 56, 305–319

    Google Scholar 

  • Maia M.D., Lopes E.P.A., Ferraz A.A.B., Barros, Fábio M.R., Domingues A.L.C., Ferraz E.M. 2007. Evaluation of splenomegaly in the hepatosplenic form of mansonic schistoso-miasis. Acta Tropica, 101, 183–186. DOI: 10.1016/j.actat-ropica.2007.01.004

    Article  Google Scholar 

  • Marnett L.J. 2000. Oxyradicals and DNA damage. Carcinogenesis, 21, 361–370. DOI:10.1093/carcin /21.3.361

    Article  CAS  Google Scholar 

  • Mendoza-Núñez V.M., Ruiz-Ramos M., Sánchez-Rodríguez M., Retana-Ugalde R., Muñoz-Sánchez J.L. 2007. Aging-related oxidative stress in healthy humans. Tohoku Journal of Experimental Medicine, 213, 261–268. DOI: 10.1620/tjem.213.261

    Article  Google Scholar 

  • Nielsen F., Mikkelsen B.B., Nielsen J.B., Andersen H.R. 1997. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clinical Chemistry, 1214, 1209–1214

    Google Scholar 

  • Pearce E.J., MacDonald A.S. 2002. The immunobiology of schistosomiasis. Nature Reviews Immunology, 2, 499–511. DOI: 10.1038/nri843

    Article  CAS  Google Scholar 

  • Pontinha N., Pessegueiro H., Barros H. 1999. Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B. Scandinavian Journal of Clinical and Laboratory Investigation, 59 343–347

    Article  CAS  Google Scholar 

  • Richter J., Lúcia A., Domingues C., Barata C.H., Prata A.R., Lambertucci J.R., 2001. Report of the Second Satellite Symposium on Ultrasound in Schistosomiasis. Memórias do Instituto Oswaldo Cruz, 96, 151–156

    Article  Google Scholar 

  • Richter J., 2000. Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Tropica, 77, 111–131

    Article  CAS  Google Scholar 

  • Santos V.N. dos., Leite-Mór M.M.B., Kondo M., Martins J.R., Nader H., Lanzoni V.P., Parise E.R. 2005. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Brazilian Journal Of Medical and Biological Research, 38, 747–753. DOI: 10.1590/S0100-879X200 5000500012

    Article  Google Scholar 

  • Sies H., Cadenas E., Symons M.C.R., Scott G., 1985. Oxidative Stress: Damage to Intact Cells and Organs [and Discussion]. Philosophical Transactions of the Royal Society B: Biological Sciences, 311, 617–631. DOI: 10.1098/rstb.1985.0168

    Article  CAS  Google Scholar 

  • Taccone-Gallucci M., Lubrano R., Meloni C., Morosetti M., Adolfo C.M.C.C. 1998. Malonyldialdehyde content of cell membranes is the most important marker of oxidative stress in haemodialysis patients. Nephrology Dialysis Transplantation, Oct; 13, 2711–2712

    Article  CAS  Google Scholar 

  • Vanheule E., Geerts A.M., Van Huysse J., Schelfhout D., Praet M., Van Vlierberghe H., De Vos M., Colle I. 2008. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis. International Journal of Experimental Pathology, 89, 419–432. DOI: 10.1111/j.1365-2613.2008.00608.x

    Article  Google Scholar 

  • Zhou X.N., Wang L.Y., Chen M.G., Wu X.H., Jiang Q.W., Chen X.Y., Zheng J. Utzinger J. 2005. The public health significance and control of schistosomiasis in China—then and now. Acta Tropica, 96, 97–105. DOI: 10.1016/j.actatropica.2005. 07.005

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Inas Abdel Aziz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdel Aziz, I., Yacoub, M., Rashid, L. et al. Malondialdehyde; Lipid peroxidation plasma biomarker correlated with hepatic fibrosis in human Schistosoma mansoni infection. Acta Parasit. 60, 735–742 (2015). https://doi.org/10.1515/ap-2015-0105

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1515/ap-2015-0105

Keywords

Navigation